Effects of an Automatic Oxygen Titration System in People With Hypoxemia During Exercise Training
Launched by SCHÖN KLINIK BERCHTESGADENER LAND · Aug 5, 2024
Trial Information
Current as of July 24, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying the effects of a new method called automatic oxygen titration on people with chronic lung disease who experience low oxygen levels, known as hypoxemia, during exercise. Instead of providing a constant flow of oxygen, this system adjusts the oxygen delivery based on the person’s current oxygen levels. The goal is to see if this method can help reduce the feeling of breathlessness, or dyspnea, during exercise training compared to the usual fixed oxygen flow.
To participate in this trial, you must be aged between 18 and 80, have chronic lung disease with low oxygen levels, and be enrolled in a pulmonary rehabilitation program. Participants will receive careful monitoring and support during their exercise sessions. This study is currently recruiting participants, and your involvement could help improve oxygen therapy for many people with similar conditions.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Chronic lung disease
- • Hypoxemia (pO2\< 55mmHg) under room air conditions (rest or during exercise) or SpO2\<88% during exercise
- • established Long-term oxygen therapy or given indication for a Long-term oxygen therapy/ supplemental oxygen therapy for exercise
- • Age: 18 to 80 years
- • Participation in an inpatient pulmonary rehabilitation program (Schoen Klinik BGL, Germany)
- • Written informed consent
- Exclusion Criteria:
- • - Acute exacerbation of underlying pulmonary disease requiring cessation of exercise training.
About Schön Klinik Berchtesgadener Land
Schön Klinik Berchtesgadener Land is a leading healthcare institution specializing in orthopedic and rehabilitation medicine, located in the picturesque Berchtesgaden region of Germany. Renowned for its patient-centered approach, the clinic combines state-of-the-art medical technology with a holistic treatment philosophy, aiming to enhance recovery and improve the quality of life for its patients. As a clinical trial sponsor, Schön Klinik Berchtesgadener Land is committed to advancing medical research and innovation, conducting rigorous studies that contribute to the development of effective therapeutic solutions in musculoskeletal health and beyond. The institution fosters collaborations with academic and industry partners to ensure the highest standards of clinical research and patient care.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Schönau A.Königssee, Bavaria, Germany
Patients applied
Trial Officials
Andreas Rembert Koczulla, Prof. Dr.
Principal Investigator
Philipps University Marburg
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported